Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Hawkey

Showing results (271-280 of 279) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 279 results.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's diseaseJ C Mansfield, M Parkes, A B Hawthorne, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?L J Tata, P J Fortun, R B Hubbard, et al.
Health Technology Assessment (Winchester, England)|August 22, 2025
Eradication of <i>Helicobacter pylori</i> for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCTC J Hawkey, Anthony J Avery, Carol Ac Coupland, et al.
The New England Journal of Medicine|November 23, 2000
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupC Bombardier, L Laine, A Reicin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cellsR J Coffey, C J Hawkey, L Damstrup, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinN D Yeomans, A I Lanas, N J Talley, et al.
Rheumatology (Oxford, England)|September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2P Brooks, P Emery, J F Evans, et al.
Gut|March 1, 1996
A national training programme for gastroenterology and hepatologyM J Farthing, R P Walt, R N Allan, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsR Caprilli, M A Gassull, J C Escher, et al.
Pageof 28

Showing results (271-280 of 279) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 279 results.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's diseaseJ C Mansfield, M Parkes, A B Hawthorne, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?L J Tata, P J Fortun, R B Hubbard, et al.
Health Technology Assessment (Winchester, England)|August 22, 2025
Eradication of <i>Helicobacter pylori</i> for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCTC J Hawkey, Anthony J Avery, Carol Ac Coupland, et al.
The New England Journal of Medicine|November 23, 2000
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupC Bombardier, L Laine, A Reicin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cellsR J Coffey, C J Hawkey, L Damstrup, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinN D Yeomans, A I Lanas, N J Talley, et al.
Rheumatology (Oxford, England)|September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2P Brooks, P Emery, J F Evans, et al.
Gut|March 1, 1996
A national training programme for gastroenterology and hepatologyM J Farthing, R P Walt, R N Allan, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsR Caprilli, M A Gassull, J C Escher, et al.
Pageof 28